Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin pharmacokinetics/pharmacodynamics during continuous renal replacement therapy in critically ill patients
2021-001019-95Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Jun 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of colistin in bacterial disease and Bacterial sepsis, sponsored by Policlinico Gemelli. Primary endpoint: Colimycin plasma levels after IV infusion. Started Jun 2021; status: completed.
02
Drugs
colistin
03
Conditions
bacterial diseaseBacterial sepsis
Beyond the preview
Go deeper on 2021-001019-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001019-95.